ABSI
Price
$2.63
Change
-$0.77 (-22.65%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
506.13M
131 days until earnings call
Intraday BUY SELL Signals
CRDF
Price
$2.15
Change
-$0.09 (-4.02%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
151.9M
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs CRDF

Header iconABSI vs CRDF Comparison
Open Charts ABSI vs CRDFBanner chart's image
Absci
Price$2.63
Change-$0.77 (-22.65%)
Volume$83.2K
Capitalization506.13M
Cardiff Oncology
Price$2.15
Change-$0.09 (-4.02%)
Volume$23.53K
Capitalization151.9M
ABSI vs CRDF Comparison Chart in %
ABSI
Daily Signal:
Gain/Loss:
CRDF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABSI vs. CRDF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and CRDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ABSI: $3.40 vs. CRDF: $2.24)
Brand notoriety: ABSI and CRDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 74% vs. CRDF: 43%
Market capitalization -- ABSI: $506.13M vs. CRDF: $151.9M
ABSI [@Biotechnology] is valued at $506.13M. CRDF’s [@Biotechnology] market capitalization is $151.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileCRDF’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • CRDF’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than CRDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while CRDF’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 5 bearish.
  • CRDF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABSI is a better buy in the short-term than CRDF.

Price Growth

ABSI (@Biotechnology) experienced а -10.76% price change this week, while CRDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 24, 2026.

CRDF is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($506M) has a higher market cap than CRDF($152M). ABSI YTD gains are higher at: 29.771 vs. CRDF (-48.387). CRDF has higher annual earnings (EBITDA): -53.95M vs. ABSI (-100.08M). ABSI has more cash in the bank: 117M vs. CRDF (71M). CRDF has less debt than ABSI: CRDF (1.19M) vs ABSI (7.41M). ABSI has higher revenues than CRDF: ABSI (4.14M) vs CRDF (545K).
ABSICRDFABSI / CRDF
Capitalization506M152M333%
EBITDA-100.08M-53.95M186%
Gain YTD29.771-48.387-62%
P/E RatioN/AN/A-
Revenue4.14M545K759%
Total Cash117M71M165%
Total Debt7.41M1.19M625%
FUNDAMENTALS RATINGS
CRDF: Fundamental Ratings
CRDF
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSICRDF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend about 1 month ago
89%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signal:
Gain/Loss:
CRDF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VVOIX25.100.13
+0.52%
Invesco Value Opportunities Y
ATEYX171.910.59
+0.34%
AB Sustainable Global Thematic Advisor
TRDFX13.020.03
+0.23%
Steward Values Enhanced SmMidCapA
JLFSX12.650.02
+0.16%
JHancock Global Climate Action I
WWICX12.780.02
+0.16%
Westwood Income Opportunity C

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-1.45%
RXRX - ABSI
63%
Loosely correlated
-1.27%
CRSP - ABSI
59%
Loosely correlated
-5.47%
ABCL - ABSI
55%
Loosely correlated
-1.00%
BEAM - ABSI
53%
Loosely correlated
-2.71%
DNA - ABSI
51%
Loosely correlated
-1.18%
More

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with MRVI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then MRVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
-2.18%
MRVI - CRDF
44%
Loosely correlated
N/A
NAMS - CRDF
41%
Loosely correlated
-3.96%
ORMP - CRDF
39%
Loosely correlated
+2.07%
NRIX - CRDF
39%
Loosely correlated
-5.37%
ABSI - CRDF
37%
Loosely correlated
-1.45%
More